Results

Total Results: 1,939 records

Showing results for "event".

401. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - to 40 hypertensive patients with no comorbidities on therapeutic doses of beta-blockers, a single event … (and we corroborated) that the study referred to in this conclusion did not report this adverse event … to 40 hypertensive patients with no comorbidities on therapeutic doses of beta-blockers, a single event

402. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - The only exception would be studies in those with acute coronary syndrome where event rates are high … The combination arm reported 8 patients out of 256 experienced a serious adverse event, while the … These outcomes were abstracted individually across studies, however, the event rates reported were typically

403. Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
     May 19, 2010 - Current Page Topic Timeline May. 19, 2010 Research Protocol Jun. 1, 2011 Topic Suggestion Sep. 27, 2011 Systematic Review Jan. 12, 2012 Disposition of Comments Report Jul. 5, 2016 Surveillance Report Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update Research Protocol Archi…

404. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
     October 01, 2019 - Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD Purpose of Review To evaluate the effectiveness and harms of pharmacologic and nonpharmacologic treatments for exacerbations of chronic obstructive pulmonary disease. Key Messages • Antibiotic therapy in…

405. Test-Performance-Metrics Appendixes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
     January 01, 2005 - purposes because they give the clinician an indication of the likelihood of disease or a specific event

406. Omega-3 Fatty Acids and Maternal and Child Health: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
     October 01, 2016 - Only 35 percent reported an active mode of collection of adverse event information, and of the studies … that reported serious adverse events (or lack thereof), most did not define “serious adverse event

407. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - , versus 55.7% given placebo; serious adverse event rates were 1.6%, 2.4%, and 4.1%, respectively.5 … Similar adverse event rates were reported for secukinumab 75 mg (57.5%), 150 mg (62.5%), and placebo … in the pooled secukinumab group and 58.2% of patients in the placebo group reported an adverse event … , 77%, and 64% for baricitinib 2 mg, baricitinib 4 mg, and placebo, respectively; serious adverse event … and 67% for methotrexate, baricitinib, and baricitinib/methotrexate, respectively; serious adverse event

408. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - 1 Comparative Effectiveness Review Number 37 Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment Executive Summary Objectives This systematic review evaluates the evidence regarding the potential benefits and harms of: (1) screening adults for early-stage chronic kidney disease (CKD stages…

409. Comparative Effectiveness of Diagnosis and Treatment of Obstructive Sleep Apnea in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/sleep-apnea/research-protocol
     March 15, 2010 - medications) Non-insulin dependent diabetes (diagnosis, resolution, start or end treatment) Depression event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

410. Slide 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_goalsetting.pdf
     May 18, 2012 - Slide 1 Goal Setting Jyoti Gupta, MPH, Senior Public Engagement Associate Public Agenda 1 Purposes of Goal Setting • To choose the right strategies and methodologies for engagement • To be clear and honest about what one can reasonably expect to be the outcomes 2 Goals of Del…

411. S9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
     October 01, 2007 - integrated into the Health Plan Management System), beneficiary enrollment files, and prescription drug event … Medicare Part D Prescription Drug Event (PDE) Data.

412. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: May 19, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update I. Background and Objectives for the Sys…

413. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - using the DerSimonian and Laird random-effects model,33 and Peto odds ratios were calculated when event … of 40 hypertensive patients with no comorbidities on therapeutic doses of beta-blockers, a single event … What Is a Serious Adverse Event? www.fda.gov/safety/medwatch/howtoreport/ ucm053087.htm.

414. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - risks are not covered by KQ3 but new research evidence is available and fetal toxicity and adverse event … As such, it is difficult to assure that the case population had the same baseline risk of an acute event … administering the drug in women of childbearing potential) to warnings and precautions; the adverse event … As such, it is difficult to assure that the case population had the same baseline risk of an acute event

415. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - risks are not covered by KQ3 but new research evidence is available and fetal toxicity and adverse event … As such, it is difficult to assure that the case population had the same baseline risk of an acute event … administering the drug in women of childbearing potential) to warnings and precautions; the adverse event … As such, it is difficult to assure that the case population had the same baseline risk of an acute event

416. Comparative Effectiveness of Management Strategies for Renal Artery Stenosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-artery-stenosis/research
     October 24, 2006 - Current Page Topic Timeline Jan. 1, 2005 Topic Initiated Nov. 19, 2007 Systematic Review Jun. 13, 2013 Surveillance Report Comparative Effectiveness of Management Strategies for Renal Artery Stenosis Systematic Review Archived October 24, 2006 Web Version [NLM Site] Download Main Document PDF 1.8 MB …

417. Value Dossier (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-fecal-incontinence-supporting.pdf
     June 19, 2020 - A third patient experienced a serious treatment-related adverse event of rectal abscess during the … These events resolved following treatment without sequalae within 35 days of event onset.9 • The … A third patient experienced a serious treatment-related adverse event of rectal abscess during the … These events resolved following treatment without sequalae within 35 days of event onset.9 Another … In the open phase, a third patient experienced a serious treatment-related adverse event of rectal

418. Treatment for Hepatitis C Virus Infection in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c/research
     November 27, 2012 - Current Page Topic Timeline Feb. 14, 2011 Topic Initiated Nov. 30, 2011 Research Protocol Nov. 27, 2012 Systematic Review Apr. 15, 2013 Disposition of Comments Report Oct. 20, 2015 Surveillance Report Treatment for Hepatitis C Virus Infection in Adults Systematic Review Archived November 27, 2012 Web Version [NLM …

419. Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research
     October 27, 2015 - Current Page Topic Timeline Oct. 3, 2012 Topic Suggestion Jul. 21, 2014 Research Protocol Oct. 27, 2015 Systematic Review Feb. 15, 2016 Disposition of Comments Report Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer Systematic Review Archived October 27, 2015 Web Version [NLM Si…

420. Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/skin-cancer/research
     December 08, 2017 - Current Page Topic Timeline May. 6, 2016 Topic Initiated Jun. 23, 2016 Research Protocol Dec. 8, 2017 Systematic Review Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin Systematic Review December 8, 2017 Download Main Document PDF 8.5 MB Related Files Download Evidence Summary [PDF · …